Mapping the Interactions of Dengue Virus NS1 Protein with Human Liver Proteins Using a Yeast Two-Hybrid System: Identification of C1q as an Interacting Partner

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Silva, Emiliana M ^a   Conde, Jonas N ^a   Allonso, Diego ^a   Nogueira, Mauricio L ^b   Mohana Borges, Ronaldo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; NONSTRUCTURAL PROTEIN 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; COMPLEMENT COMPONENT C1Q GENE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; VIRUS PATHOGENESIS;

ANIMALS; CARRIER PROTEINS; CELL LINE; COMPLEMENT C1Q; CRICETINAE; GENE LIBRARY; HUMANS; LIVER; PLASMIDS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN TRANSPORT; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84875040462     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057514     Document Type: Article

References (62)

1. Kyle JL, Harris E, (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
2. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8 (12) Suppl: S7-16.
3. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
4. Halstead SB, (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
5. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
6. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, et al. (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186: 1165-1168.
7. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, et al. (2003) High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305: 330-338.
8. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120: 653-669.
9. Guzman MG, Kouri G, (2003) Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 27: 1-13.
10. Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, et al. (2005) Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol 174: 395-403.
11. Restrepo BN, Isaza DM, Salazar CL, Ramirez R, Ospina M, et al. (2008) Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. Rev Soc Bras Med Trop 41: 6-10.
12. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8: 86.
13. Juffrie M, Meer GM, Hack CE, Haasnoot K, Sutaryo, et al. (2001) Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 65: 70-75.
14. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M, (1998) Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161: 6338-6346.
15. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 59: 329-334.
16. Cardier JE, Marino E, Romano E, Taylor P, Liprandi F, et al. (2005) Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 30: 359-365.
17. Hober D, Poli L, Roblin B, Gestas P, Chungue E, et al. (1993) Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48: 324-331.
18. Allonso D, Belgrano FS, Calzada N, Guzman MG, Vazquez S, et al. (2012) Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection. J Clin Virol 55: 214-219.
19. Bokisch VA, Top FH Jr, Russell PK, Dixon FJ, Muller-Eberhard HJ, (1973) The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 289: 996-1000.
20. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193: 1078-1088.
21. Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, et al. (2006) Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 43: 1023-1030.
22. Nascimento EJ, Silva AM, Cordeiro MT, Brito CA, Gil LH, et al. (2009) Alternative complement pathway deregulation is correlated with dengue severity. PLoS One 4: e6782.
23. Rosen L, Drouet MT, Deubel V, (1999) Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am J Trop Med Hyg 61: 720-724.
24. Paes MV, Lenzi HL, Nogueira AC, Nuovo GJ, Pinhao AT, et al. (2009) Hepatic damage associated with dengue-2 virus replication in liver cells of BALB/c mice. Lab Invest 89: 1140-1151.
25. Mackenzie JM, Jones MK, Young PR, (1996) Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232-240.
26. Young PR, Hilditch PA, Bletchly C, Halloran W, (2000) An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 38: 1053-1057.
27. Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T, et al. (2008) Association of dengue virus NS1 protein with lipid rafts. J Gen Virol 89: 2492-2500.
28. Jacobs MG, Robinson PJ, Bletchly C, Mackenzie JM, Young PR, (2000) Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J 14: 1603-1610.
29. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, et al. (2002) Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 40: 376-381.
30. Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, et al. (2011) Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc Natl Acad Sci U S A 108: 8003-8008.
31. Falconar AK, (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142: 897-916.
32. Avirutnan P, Fuchs A, Hauhart RE, Somnuke P, Youn S, et al. (2010) Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med 207: 793-806.
33. Con-LePoder S, Drouet MT, Roux P, Frenkiel MP, Arborio M, et al. (2005) The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J Virol 79: 11403-11411.
34. Allonso D, Rosa MS, Coelho DR, Costa SM, Nogueira RM, et al. (2011) Properly folded Dengue virus NS1 protein expressed in E. coli generates polyclonal antibodies that enable sensitive and early dengue diagnosis. J Virol Methods 175: 109-116.
35. Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend RR, et al. (2006) West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A 103: 19111-19116.
36. Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, et al. (2011) Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation. J Immunol 187: 424-433.
37. Duncan AR, Winter G, (1988) The binding site for C1q on IgG. Nature 332: 738-740.
38. Falconar AK, (2008) Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines. Clin Vaccine Immunol 15: 549-561.
39. Pryor MJ, Wright PJ, (1994) Glycosylation mutants of dengue virus NS1 protein. J Gen Virol 75 (Pt 5) (): 1183-1187.
40. Loos M, Martin H, Petry F, (1989) The biosynthesis of C1q, the collagen-like and Fc-recognizing molecule of the complement system. Behring Inst Mitt pp. 32-41.
41. Armbrust T, Nordmann B, Kreissig M, Ramadori G, (1997) C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: up-regulation by dexamethasone, down-regulation by interferon gamma, and lipopolysaccharide. Hepatology 26: 98-106.
42. Chang NS, Intrieri C, Mattison J, Armand G, (1994) Synthetic polysulfated hyaluronic acid is a potent inhibitor for tumor necrosis factor production. J Leukoc Biol 55: 778-784.
43. Avirutnan P, Mehlhop E, Diamond MS, (2008) Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine 26 (Suppl 8):: I100-I107.
44. Lambris JD, Ricklin D, Geisbrecht BV, (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132-142.
45. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, et al. (2000) Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol 164: 4178-4184.
46. Volanakis JE, (2002) The role of complement in innate and adaptive immunity. Curr Top Microbiol Immunol 266: 41-56.
47. Bartholomew RM, Esser AF, Muller-Eberhard HJ, (1978) Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med 147: 844-853.
48. Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, et al. (1991) Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med 174: 1417-1424.
49. Susal C, Kirschfink M, Kropelin M, Daniel V, Opelz G, (1994) Complement activation by recombinant HIV-1 glycoprotein gp120. J Immunol 152: 6028-6034.
50. Kurosu T, Chaichana P, Yamate M, Anantapreecha S, Ikuta K, (2007) Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. Biochem Biophys Res Commun 362: 1051-1056.
51. Mehlhop E, Nsarah-Sobrinho C, Johnson S, Engle M, Fremont DH, et al. (2007) Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2: 417-426.
52. Yamanaka A, Kosugi S, Konishi E, (2008) Infection-enhancing and-neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. J Virol 82: 927-937.
53. Mehlhop E, Nelson S, Jost CA, Gorlatov S, Johnson S, et al. (2009) Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe 6: 381-391.
54. Gabay C, Kushner I, (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454.
55. Black PH, (2003) The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 17: 350-364.
56. Schouten M, Wiersinga WJ, Levi M, van der PT, (2008) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83: 536-545.
57. Huerta-Zepeda A, Cabello-Gutierrez C, Cime-Castillo J, Monroy-Martinez V, Manjarrez-Zavala ME, et al. (2008) Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost 99: 936-943.
58. WHO (2009) Dengue guidelines for diagnosis, treatment, prevention and control.
59. Chua JJ, Bhuvanakantham R, Chow VT, Ng ML, (2005) Recombinant non-structural 1 (NS1) protein of dengue-2 virus interacts with human STAT3beta protein. Virus Res 112: 85-94.
60. Silva BM, Sousa LP, Gomes-Ruiz AC, Leite FG, Teixeira MM, et al. (2011) The dengue virus nonstructural protein 1 (NS1) increases NF-kappaB transcriptional activity in HepG2 cells. Arch Virol 156: 1275-1279.
61. He G, Karin M, (2011) NF-kappaB and ST. Cell Res 21: 159-168.
62. Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, et al. (1999) Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 73: 6104-6110.